AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45

Authors: RAMSEYGOLDMAN R TYMKOW C KOCH E RUBIN C LOU H DUNLOP D
Citation: R. Ramseygoldman et al., BONE-MINERAL DENSITY (BMD) IN WOMEN WITH LUPUS MATCHED TO HEALTHY CONTROLS - PRELIMINARY-RESULTS, Journal of investigative medicine, 46(7), 1998, pp. 275-275

Authors: RAMSEYGOLDMAN R MATTAI SA SCHILLING E CHIU YL ALO CJ HOWE HL MANZI S
Citation: R. Ramseygoldman et al., INCREASED RISK OF MALIGNANCY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of investigative medicine, 46(5), 1998, pp. 217-222

Authors: RAMSEYGOLDMAN R
Citation: R. Ramseygoldman, THE EFFECT OF PREGNANCY ON THE VASCULITIDES, Scandinavian journal of rheumatology, 1998, pp. 116-117

Authors: RAMSEYGOLDMAN R
Citation: R. Ramseygoldman, THE RISK OF CYTOTOXIC DRUGS DURING PREGNANCY, Scandinavian journal of rheumatology, 1998, pp. 133-135

Authors: OSTENSEN M RAMSEYGOLDMAN R
Citation: M. Ostensen et R. Ramseygoldman, TREATMENT OF INFLAMMATORY RHEUMATIC DISORDERS IN PREGNANCY - WHAT ARETHE SAFEST TREATMENT OPTIONS, Drug safety, 19(5), 1998, pp. 389-410

Authors: RAMSEYGOLDMAN R TYMKOW G KOCH E RUBIN C LOU H DUNLOP D
Citation: R. Ramseygoldman et al., BONE-MINERAL DENSITY (BMD) IN WOMEN WITH LUPUS MATCHED TO HEALTHY CONTROLS - PRELIMINARY-RESULTS, Arthritis and rheumatism, 41(9), 1998, pp. 207-207

Authors: MOSER KL NEAS BR SALMON JE YU H MCGUIRE C ASUNDI N BRUNER GR FOX J KELLY J HENSHALL S BACINO D DIETZ M HOGUE R KOELSCH G NIGHTINGALE L ABDOU N ALBERT D CARSON C GINZLER E MCKOWEN K PETRIE M RAMSEYGOLDMAN R TREADWELL E WALLACE D WILSON J WOLF R SHAVER T JAMES JA HARLEY JB
Citation: Kl. Moser et al., GENOME SCAN OF HUMAN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) IDENTIFIES MULTIPLE LOCI INFLUENCED BY RACIAL ORIGIN, Arthritis and rheumatism, 41(9), 1998, pp. 1502-1502

Authors: SPRAGUE SM RAMSEYGOLDMAN R DUNLOP D STUART FP STUART J SALINGER M MADISON L STERN PH LANGMAN CB
Citation: Sm. Sprague et al., SELF-REPORTED FRACTURES IN PATIENTS UNDERGOING SOLID-ORGAN TRANSPLANTATION, Journal of the American Society of Nephrology, 8, 1997, pp. 2587-2587

Authors: RAMSEYGOLDMAN R SCHILLING E
Citation: R. Ramseygoldman et E. Schilling, IMMUNOSUPPRESSIVE DRUG-USE DURING PREGNANCY, Rheumatic diseases clinics of North America, 23(1), 1997, pp. 149

Authors: RAMSEYGOLDMAN R DUNLOP D STUART F KAUFMAN D ABECASIS M SALINGER M SPRAGUE S
Citation: R. Ramseygoldman et al., INCIDENCE OF SELF-REPORTED FRACTURES IN PATIENTS FOLLOWING SOLID-ORGAN TRANSPLANTATION, Journal of bone and mineral research, 12, 1997, pp. 566-566

Authors: BURT RK TRAYNOR A RAMSEYGOLDMAN R
Citation: Rk. Burt et al., HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR SYSTEMIC LUPUS-ERYTHEMATOSUS, The New England journal of medicine, 337(24), 1997, pp. 1777-1778

Authors: BURT RK TRAYNOR A RAMSEYGOLDMAN R SCHROEDER J POPE R SCHUENING F GRAZIANO F ROSEN S GORDON L
Citation: Rk. Burt et al., HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS, Blood, 90(10), 1997, pp. 4549-4549

Authors: RAMSEYGOLDMAN R MATTAI SA CHIU YL ALO CJ HOWE HL
Citation: R. Ramseygoldman et al., RISK OF CANCER IN CAUCASIAN (C) AND AFRICAN-AMERICAN (A-A) LUPUS PATIENTS, Arthritis and rheumatism, 40(9), 1997, pp. 787-787

Authors: WU J BANSAL V ARNETT F REVEILLE J GINZLER E GOURLEY M RAMSEYGOLDMAN R SALMON J EDBERG J KIMBERLY R
Citation: J. Wu et al., THE FC-GAMMA-RIIIA 176F V POLYMORPHISM ASSOCIATES WITH THE SLE PHENOTYPE IN CAUCASIANS AND AFRICAN-AMERICANS (AA)/, Arthritis and rheumatism, 40(9), 1997, pp. 1709-1709

Authors: RAMSEYGOLDMAN R SCHILLING E
Citation: R. Ramseygoldman et E. Schilling, OPTIMUM USE OF DISEASE-MODIFYING AND IMMUNOSUPPRESSIVE ANTIRHEUMATIC AGENTS DURING PREGNANCY AND LACTATION (VOL 5, PG 40, 1996), CLINICAL IMMUNOTHERAPEUTICS, 6(2), 1996, pp. 142-142

Authors: RAMSEYGOLDMAN R SCHILLING E
Citation: R. Ramseygoldman et E. Schilling, OPTIMUM USE OF DISEASE-MODIFYING AND IMMUNOSUPPRESSIVE ANTIRHEUMATIC AGENTS DURING PREGNANCY AND LACTATION, CLINICAL IMMUNOTHERAPEUTICS, 5(1), 1996, pp. 40-58

Authors: RAMSEYGOLDMAN R MATTAI SA SCHILLING EM DAUGHERTY C RAIRIE JE CONTE C MANZI S
Citation: R. Ramseygoldman et al., ASSESSMENT OF CANCER RISK IN 2 COHORTS OF PATIENTS WITH SLE, Journal of investigative medicine, 44(7), 1996, pp. 388-388

Authors: DREVLOW BE SCHILLING EM KHABBAZ RF KAPLAN JE FUKUDA K SINACORE J RAMSEYGOLDMAN R
Citation: Be. Drevlow et al., RETROVIRAL RISK-FACTORS IN PATIENTS WITH AUTOIMMUNE-DISEASE, Journal of rheumatology, 23(3), 1996, pp. 428-431

Authors: DESAIMEHTA A LU LJ RAMSEYGOLDMAN R DATTA SK
Citation: A. Desaimehta et al., HYPEREXPRESSION OF CD40 LIGAND BY B-CELLS AND T-CELLS IN HUMAN LUPUS AND ITS ROLE IN PATHOGENIC AUTOANTIBODY PRODUCTION, The Journal of clinical investigation, 97(9), 1996, pp. 2063-2073

Authors: SALMON JE MILLARD S SCHACHTER LA ARNETT FC GINZLER EM GOURLEY MF RAMSEYGOLDMAN R PETERSON MGE KIMBERLY RP
Citation: Je. Salmon et al., FC-GAMMA-RIIA ALLELES ARE HERITABLE RISK-FACTORS FOR LUPUS NEPHRITIS IN AFRICAN-AMERICANS, The Journal of clinical investigation, 97(5), 1996, pp. 1348-1354

Authors: RAMSEYGOLDMAN R MATTAI SA SCHILLING E DAUGHERTY D RAIRIE J CONTE C MANZI S
Citation: R. Ramseygoldman et al., ASSESSMENT OF CANCER RISK IN 2 COHORTS OF PATIENTS WITH SLE, Arthritis and rheumatism, 39(9), 1996, pp. 257-257

Authors: WATERS TM RAMSEYGOLDMAN R CHANG R PILLOFF A SEQUEIRA W
Citation: Tm. Waters et al., ACCESS TO HEALTH-CARE IN SLE, Arthritis and rheumatism, 39(9), 1996, pp. 276-276

Authors: RAMSEYGOLDMAN R SCHILLING E DAUGHERTY C COOTE C RAIRIE J MANZI S
Citation: R. Ramseygoldman et al., FRACTURES IN PATIENTS WITH LUPUS, Arthritis and rheumatism, 39(9), 1996, pp. 373-373

Authors: KARLSON EW RIVEST C RAMSEYGOLDMAN R PORTIN PR SHADICK NA PARTRIDGE AJ LEW RA WRIGHT EA DALTROY LG LIANG MH
Citation: Ew. Karlson et al., VALIDATION OF A SELF-ADMINISTERED SLE DISEASE-ACTIVITY MEASURE (SA-SLAM) FOR POPULATION STUDIES, Arthritis and rheumatism, 39(9), 1996, pp. 1092-1092

Authors: MANZI S RAIRIE JE CARPENTER AB KELLY RH JAGARLAPUDI SP SEREIKA SM MEDSGER TA RAMSEYGOLDMAN R
Citation: S. Manzi et al., SENSITIVITY AND SPECIFICITY OF PLASMA AND URINE COMPLEMENT SPLIT PRODUCTS AS INDICATORS OF LUPUS DISEASE-ACTIVITY, Arthritis and rheumatism, 39(7), 1996, pp. 1178-1188
Risultati: 1-25 | 26-45